UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 22,
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more NovaBay Pharmaceuticals Charts.
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more NovaBay Pharmaceuticals Charts.

Novabay Pharmaceuticals, Inc. News

NovaBay Pharmaceuticals to Hold 2024 First Quarter Conference Call on May 9, 2024
Friday 3 May 2024 (2 days ago) • Business Wire
NovaBay Pharmaceuticals Announces New and Enhanced Direct-to-Consumer Marketing to Efficiently Engage Customers and Drive Avenova Sales
Monday 22 April 2024 (2 weeks ago) • Business Wire
NovaBay Pharmaceuticals Receives a NYSE American Notice Regarding Stockholder Equity
Friday 19 April 2024 (2 weeks ago) • Business Wire
NovaBay Pharmaceuticals Reports Preliminary Eyecare and Wound Care Revenue Increased 13% for the First Quarter of 2024 on Lower Sales and Marketing Expenses
Wednesday 17 April 2024 (3 weeks ago) • Business Wire
NovaBay Pharmaceuticals Reports 2023 Fourth Quarter and Full Year Financial Results
Tuesday 26 March 2024 (1 month ago) • Business Wire
NovaBay Pharmaceuticals to Hold 2023 Fourth Quarter and Full Year Conference Call on March 26, 2024
Monday 25 March 2024 (1 month ago) • Business Wire
NovaBay Pharmaceuticals Announces Agreement to Sell its DERMAdoctor Skincare Business Segment; Announces Preliminary Financial Results for Fourth Quarter and Year Ended December 31, 2023
Thursday 14 March 2024 (2 months ago) • Business Wire
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)
NovaBay Pharmaceuticals Reports 64% Year-Over-Year Growth in Avenova Unit Subscription-Based Sales
Tuesday 30 January 2024 (3 months ago) • Business Wire
Form 8-K - Current report
Wednesday 10 January 2024 (4 months ago) • Edgar (US Regulatory)
NovaBay Pharmaceuticals and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products in the European Union Through Sonoma’s Extensive Distributor Network
Tuesday 9 January 2024 (4 months ago) • Business Wire

More Novabay Pharmaceuticals, Inc. News Articles